Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-12-04 19:00:27
Reporting Period:
Accepted Time:
2019-12-04 19:00:27
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1280776 Immunic Inc. IMUX Pharmaceutical Preparations (2834) 562358443
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591098 Duane Nash 1200 Avenue Of The Americas, Suite 200
New York NY 10036
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-02 22,157 $0.00 22,362 No 4 M Direct
Common Stock Disposition 2019-12-03 7,930 $7.15 14,432 No 4 F Direct
Common Stock Disposition 2019-12-04 4,400 $6.96 10,032 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-12-02 22,157 $0.00 22,157 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
864,159 No 4 M Direct
  1. Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
  2. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs granted to the Reporting Person.
  3. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $7.1508 and $7.1572 per share.
  4. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  5. On January 11, 2019, the Reporting Person was granted 886,316 restricted stock units as consideration of cancelled stock options. Pursuant to the Reporting Person's amended RSU Agreement, RSUs that vested prior to April 22, 2019 were settled on December 2, 2019.